.png)
.png)
Latest news from BIA
BIA welcomes Global AMR Action Fund to tackle antimicrobial resistance
Steve Bates OBE, Chief Executive of the BIA said: “Antimicrobial resistance (AMR) is one of the key global challenges of our times. Despite being a global health (and BIA) policy focus for years, no market solution has yet delivered the incentives needed to make novel antibiotic development an attractive investment prospect.
BIA welcomes new deal between Vertex and NHS England
Steve Bates OBE, Chief Executive of the BIA said: “It’s fantastic to see the NHS and Vertex strike a lightning quick deal to enable NHS cystic fibrosis patients to access this important breakthrough therapy.
Investment in UK biotech remains strong latest data from the BIA shows
New figures published today (Monday 22 June 2020) by the UK BioIndustry Association (BIA) and Clarivate reveal that the UK biotech sector raised £585million from March to May 2020. A total of £894m has now been raised from all sources in the first half of 2020, surpassing the £831m raised in the same period in 2018, which was a record-breaking year.
£30 million Biomedical Catalyst to launch following successful BIA campaign
Innovative biotech companies will be able to access a share of £30 million in grant funding through a relaunched Biomedical Catalyst, Innovate UK’s CEO Ian Campbell confirmed today.
An Essential First Step to Market Access for Medicines
UK PharmaScan is a database of information on new medicines, indications and formulations in the pharmaceutical pipeline. It is the primary source of information used by all of the UK’s national horizon scanning organisations and NHS England to enable early engagement in planning and preparing the NHS for the introduction of new medicines and to support faster NHS adoption.
Horizon Discovery introduces Cas9 and dCas9-VPR stable cell lines to simplify and accelerate CRISPR gene editing workflows
QC-validated cell lines optimized to work alongside Horizon’s Edit-R predesigned sgRNA products and DharmaFECT transfection reagents
CTI Named #1 CRO in the World for Quality at 2020 Clinical and Research Excellence Awards
CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization (CRO) was named Champion in multiple categories of the 2020 CRO Leadership Awards, and was the only CRO named as Champion in the Quality category.
KQ Labs opens applications for early stage data-driven health start-ups for its third annual accelerator programme and announces LifeArc as a strategic partner
KQ Labs is now accepting applications for its third cohort of companies. Early stage data-driven health companies are invited to apply
Guest Blog|In2scienceUK Covid-19 response
The BIA is a supporter of the the award winning charity In2scienceUK. This year In2scienceUK has launched an ambitious Covid-19 response allowing young people across the country to gain essential skills, role models and knowledge on STEM Skills and careers. In this blog, their Development Officer Luke McKelvey tells us about the programme and how BIA members can get involved.
CEO Update|Monday 06 July
It was great to see NHS England agree a deal with BIA member Vertex last week, to enable their new cystic fibrosis drug combination Kaftrio available to NHS patients. This is brilliant news for the cystic fibrosis community with nine in 10 patients set to benefit from this life-transforming medicine.
Guest Blog|COVID-19 Patent pooling – Sink or swim?
Recently, patent sharing for a COVID-19 vaccine has been back on the news agenda with the launch of the Covid-19 Technology Access Pool (C-TAP) by the World Health Organization.
CEO Update|Monday 29 June
Thank you to all members who made last week’s Life Science Leadership Summit such a success. It was fantastic to get positive feedback on our pioneering virtual conference and to hear such inspiring contributions from a range of sector leaders, as well as meeting vibrant innovative biotech companies during the Innovation Showcase.
Please find a selection of featured BIA publications below. To see our full publications library, click here.
Influencing and shaping our sector | BIA update: October 2019 - January 2020
This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences sector, from October 2019 to January 2020.
Global and growing - UK biotech financing in 2019
New figures published today (Wednesday 22 January 2020) by the UK BioIndustry Association (BIA) and Informa Pharma Intelligence reveal that the UK biotech sector raised £1.3 billion in 2019.
UK life sciences: Catalysing investment and growth
This updated interim report sets out how the UK life sciences sector is driving investment and growth and makes the case for increased cost-effective public investment in the sector.
BIA biotech manifesto 2019
The United Kingdom (UK) will have a general election on Thursday, 12 December. The UK BioIndustry Association (BIA) has launched a biotech manifesto with its recommendations on how political parties can support the innovative UK life sciences sector.
